Full View

Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice

J Geurtsen, HA Banus, ER Gremmer… - Clinical and Vaccine …, 2007 - Am Soc Microbiol
Pertussis is an infectious disease of the respiratory tract that is caused by the gram-negative
bacterium Bordetella pertussis. Although acellular pertussis (aP) vaccines are safe, they are …
被引用次数：57 相关文章

Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.

J Geurtsen, HA Banus, ER Gremmer… - Clinical and Vaccine …, 2007 - europepmc.org
Pertussis is an infectious disease of the respiratory tract that is caused by the gram-negative
bacterium Bordetella pertussis. Although acellular pertussis (aP) vaccines are safe, they are …
[PDF] ru.nl

[PDF][PDF] LPS analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.

J Geurtsen, S Banus, E Gremmer… - HOSt GENEticS ANd …, 2007 - repository.ubn.ru.nl
Pertussis is an infectious disease of the respiratory tract that is caused by the gram-negative
bacterium Bordetella pertussis. Although acellular pertussis (aP) vaccines are safe, they are …
[PDF] academia.edu

[PDF][PDF] Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in Mice

J Geurtsen, HA Banus, ER Gremmer… - CLINICAL AND …, 2007 - academia.edu
MATERIALS AND METHODS Vaccines and adjuvants.(i) Series 1. The acellular (DTaP)
vaccine was a combined vaccine consisting of diphtheria toxoid, tetanus toxoid, and a 3 …
[PDF] psu.edu

[PDF][PDF] LPS analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.

J Geurtsen, S Banus, E Gremmer, H Ferguson… - LPS analogs improve …, 2007 - Citeseer
Pertussis is an infectious disease of the respiratory tract that is caused by the gram-negative
bacterium Bordetella pertussis. Although acellular pertussis (aP) vaccines are safe, they are …

[引用][C] Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice

J Geurtsen, HA Banus, ER Grernmer… - Clinical and Vaccine …, 2007 - hero.epa.gov
Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I
hypersensitivity in mice | Health & Environmental Research Online (HERO) | US EPA Jump to …
[PDF] researchgate.net

[PDF][PDF] LPS analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.

J Geurtsen, S Banus, E Gremmer… - HOSt GENEticS ANd …, 2007 - researchgate.net
Pertussis is an infectious disease of the respiratory tract that is caused by the gram-negative
bacterium Bordetella pertussis. Although acellular pertussis (aP) vaccines are safe, they are …
[PDF] core.ac.uk

[PDF][PDF] LPS analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.

J Geurtsen, S Banus, E Gremmer, H Ferguson… - HOSt GENEticS ANd …, 2007 - core.ac.uk
Pertussis is an infectious disease of the respiratory tract that is caused by the gram-negative
bacterium Bordetella pertussis. Although acellular pertussis (aP) vaccines are safe, they are …

Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice

J Geurtsen, HA Banus, ER Gremmer… - Clinical and …, 2007 - pubmed.ncbi.nlm.nih.gov
Pertussis is an infectious disease of the respiratory tract that is caused by the gram-negative
bacterium Bordetella pertussis. Although acellular pertussis (aP) vaccines are safe, they are …
[HTML] nih.gov

[HTML][HTML] Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in Mice

J Geurtsen, HA Banus, ER Gremmer… - Clinical and Vaccine …, 2007 - ncbi.nlm.nih.gov
Pertussis is an infectious disease of the respiratory tract that is caused by the gram-negative
bacterium Bordetella pertussis. Although acellular pertussis (aP) vaccines are safe, they are …